- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07727369
RePer-AGE: Reorganization of Visuo-cognitive Functions Based on Peripheral Vision With Aging (RePer-AGE)
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Visual recognition depends on the complementary contribution of central and peripheral vision. Central vision provides high spatial resolution and supports the detailed analysis required for object identification, whereas peripheral vision rapidly extracts coarse visual information that provides a global representation of the surrounding environment. According to predictive models of visual processing, this early peripheral information is used to generate predictions that facilitate the subsequent processing of detailed visual inputs.
The RePer-AGE project is based on the hypothesis that peripheral vision plays a key role in predictive visual processing and that this contribution changes during normal aging. Although aging is associated with well-documented declines in visual acuity and contrast sensitivity, particularly for high spatial frequencies, several findings suggest that the processing of coarse visual information conveyed by peripheral vision may be relatively preserved. This preserved processing may contribute to compensatory mechanisms supporting visual recognition in older adults.
RePer-AGE is a prospective, monocentric interventional study conducted at Grenoble Alpes University Hospital (CHU Grenoble Alpes) and the Laboratoire de Psychologie et NeuroCognition (LPNC, CNRS, Université Grenoble Alpes). The study will recruit 160 healthy volunteers divided into two age groups: young adults (18-30 years) and older adults (60-85 years). Participants will undergo an ophthalmological examination to ensure normal or corrected-to-normal vision and the absence of ocular disease likely to affect visual performance. Older participants will also complete a brief cognitive screening assessment.
The project combines complementary behavioral, ophthalmological, and neuroimaging approaches to investigate the respective contributions of central and peripheral vision to visual recognition.
The first research axis combines psychophysical experiments with ophthalmological assessments. Participants perform computerized visual recognition tasks specifically designed to evaluate the relative contribution of central and peripheral vision. Additional ophthalmological examinations include automated static perimetry to assess retinal sensitivity across the visual field and low-luminance visual acuity testing. These measurements will allow the relationship between retinal function and visual recognition performance to be investigated.
The second research axis combines psychophysical experiments with functional magnetic resonance imaging (fMRI). During MRI acquisition, participants perform visual recognition tasks while blood oxygen level-dependent (BOLD) activity is recorded. These data will be used to identify the cortical networks supporting predictive visual processing and to determine how these neural mechanisms are modified during normal aging.
The psychophysical paradigms are derived from previous studies conducted by the research team and investigate two complementary aspects of visual recognition. One paradigm evaluates the respective contribution of central and peripheral vision to scene categorization, whereas the second examines how semantic information extracted from peripheral vision influences the recognition of centrally presented visual stimuli through predictive mechanisms.
The primary objective of the study is to determine how central and peripheral vision differentially contribute to visual recognition and how these mechanisms are reorganized with aging. Secondary objectives include characterizing age-related changes in retinal sensitivity, examining the relationship between retinal function and behavioral performance, and identifying the neural correlates of predictive visual processing using functional MRI.
The results of RePer-AGE are expected to improve the understanding of the mechanisms underlying normal visual aging. They will provide normative reference data for future studies investigating pathological aging and visual disorders affecting central vision, and may ultimately contribute to the development of new approaches for visual assessment and rehabilitation.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Carole Peyrin, PhD
- Numero di telefono: 0033615351350
- Email: carole.peyrin@univ-grenoble-alpes.fr
Luoghi di studio
-
-
Isère
-
Grenoble, Isère, Francia, 38043
- CHU Grenoble Alpes
-
Contatto:
- Carole Peyrin, PhD
- Numero di telefono: 0033615351350
- Email: carole.peyrin@univ-grenoble-alpes.fr
-
Contatto:
- Mathilde Gallice, MD
- Numero di telefono: 0033476767575
- Email: MGallice@chu-grenoble.fr
-
Investigatore principale:
- Mathilde Gallice, MD
-
Sub-investigatore:
- Carole Peyrin, PhD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Healthy young adults aged 18 to 30 years or healthy older adults aged 60 to 85 years.
- Normal or corrected-to-normal visual acuity.
- No ophthalmological disease affecting visual function.
- For participants aged 60 years or older: Mini-Mental State Examination (MMSE) score ≥23.
- Affiliated with a national health insurance system.
- Written informed consent.
Non inclusion Criteria:
- Individuals protected under French regulations governing research involving human participants.
- Employees or individuals under the direct authority of the investigators.
- History of neurological or psychiatric disorders likely to affect visual or cognitive functions.
- Current treatment likely to alter visual function or vigilance.
- MRI contraindications (metallic implants, pacemaker, severe claustrophobia, or other MRI safety contraindications) for participation in the MRI arm only.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Psychophysics and Ophthalmology
Participants undergo psychophysical visual recognition tasks together with ophthalmological examinations, including retinal sensitivity assessment by automated perimetry and low-luminance visual acuity testing.
|
Computerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing.
Ophthalmological examinations including retinal sensitivity (Humphrey automated perimetry) and low-luminance visual acuity.
|
|
Sperimentale: Psychophysics and Functional MRI
Participants undergo psychophysical visual recognition tasks while functional magnetic resonance imaging (fMRI) is performed to investigate the neural mechanisms underlying visual recognition and predictive processing.
|
Computerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing.
Functional MRI performed during psychophysical visual recognition tasks to assess brain activity associated with visual recognition and predictive visual processing.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Behavioral performance during scene categorization tasks
Lasso di tempo: Baseline (single experimental session)
|
Behavioral performance will be assessed using accuracy and response time during computerized scene categorization tasks evaluating (1) central versus peripheral vision (EXC paradigm) and (2) semantic congruency between peripheral and central vision (VPC paradigm).
Comparisons will be performed between young and older adults.
|
Baseline (single experimental session)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Retinal sensitivity
Lasso di tempo: Baseline
|
Retinal sensitivity measured by Humphrey 30-2 automated perimetry, including Mean Deviation (MD), Pattern Standard Deviation (PSD), and retinal sensitivity thresholds.
|
Baseline
|
|
Brain activation during visual recognition
Lasso di tempo: Baseline
|
Blood oxygen level-dependent (BOLD) activity measured by functional magnetic resonance imaging during scene categorization tasks, including whole-brain analyses and regions of interest involved in visual recognition and predictive processing.
|
Baseline
|
Collaboratori e investigatori
Pubblicazioni e link utili
Pubblicazioni generali
- Faurite C, Aprile E, Kauffmann L, Mermillod M, Gallice M, Chiquet C, Cottereau BR, Peyrin C. Interaction between central and peripheral vision: Influence of distance and spatial frequencies. J Vis. 2024 Jan 2;24(1):3. doi: 10.1167/jov.24.1.3.
- Peyrin C, Roux-Sibilon A, Trouilloud A, Khazaz S, Joly M, Pichat C, Boucart M, Krainik A, Kauffmann L. Semantic and Physical Properties of Peripheral Vision Are Used for Scene Categorization in Central Vision. J Cogn Neurosci. 2021 Apr 1;33(5):799-813. doi: 10.1162/jocn_a_01689.
- Trouilloud A, Kauffmann L, Roux-Sibilon A, Rossel P, Boucart M, Mermillod M, Peyrin C. Rapid scene categorization: From coarse peripheral vision to fine central vision. Vision Res. 2020 May;170:60-72. doi: 10.1016/j.visres.2020.02.008. Epub 2020 Apr 4.
- Roux-Sibilon A, Peyrin C, Greenwood JA, Goffaux V. Radial bias in face identification. Proc Biol Sci. 2023 Jun 28;290(2001):20231118. doi: 10.1098/rspb.2023.1118. Epub 2023 Jun 28.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 38RC25.0395
- ANR-25-CE28-6333 (Altro numero di sovvenzione/finanziamento: Agence Nationale de la Recherche (ANR))
- 2026-A00492-49 (Altro identificatore: Agence nationale de sécurité du médicament et des produits de santé (ANSM))
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Periodo di condivisione IPD
Criteri di accesso alla condivisione IPD
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- CODICE_ANALITICO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .